Garri Zmudze

Garri Zmudze is the executive coordinator of the Longevity Science Foundation, an international nonprofit organization funding research on longer and healthier human lifespans. He is also a managing partner at LongeVC, a venture capital firm backing visionary biotech, and is on the advisory board for PsyMed Ventures. Garri is a seasoned business expert and angel investor with several successful exits across biotech and tech companies, including Insilico Medicine, Deep Longevity and Basepaws.

Author’s posts

Opinion
Physicians and founders are rallying behind longevity medicine, and here is what a longer, healthier human lifespan means for the crypto community.
Why longevity matters to everyone: Living longer lives in the world of Web3
Garri Zmudze
2022-07-02T15:17:00+01:00
4555
Expert Take
With many asking what’s next for NFTs, charities and nonprofits are exploring and maximizing their power for charitable giving.
NFTs: Empowering artists and charities to embrace the digital movement
Garri Zmudze
2022-05-22T12:14:00+01:00
3829
Opinion
Biotech researchers working closely with decentralized tech innovators indicates that there is an appetite for progress in the longevity sector.
The crypto world should know about longevity
Garri Zmudze
2022-02-19T14:07:00+00:00
6592
Opinion
Such principles as decentralization and tokenization will enrich the nonprofit and charitable sectors via accepting donations in crypto.
It’s time for the philanthropic sector to embrace digital currencies
Garri Zmudze
2021-12-05T07:11:00+00:00
6755
Opinion
Healthcare researchers in collaboration with crypto innovators might prove that a longer and healthier lifespan is an attainable reality.
The future of longevity lies with digital currency visionaries
Garri Zmudze
2021-10-29T17:17:16+01:00
11410
Opinion
Implementing artificial intelligence and blockchain technology into healthcare and medicine is key to unlocking human longevity.
The next generation of data-driven healthcare is here
Garri Zmudze
2021-09-26T15:07:00+01:00
9968

Follow us on Facebook